Affordable Access

Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation.

Authors
  • Hasegawa, H
  • Kadowaki, S
  • Takahashi, H
  • Iwasaki, T
  • Tamura, S
  • Kurata, T
Type
Published Article
Journal
Vaccine
Publisher
Elsevier
Publication Date
May 22, 2000
Volume
18
Issue
23
Pages
2560–2565
Identifiers
PMID: 10775790
Source
Medline
License
Unknown

Abstract

The effect of sublethal gamma-ray irradiation on the protection conferred by a nasal influenza vaccine was investigated in BALB/c mice. A radiation dose of 7 Gy was selected as the sublethal dose as this caused exacerbation of the influenza but was not lethal in the mouse model. Mice were irradiated 7 days before, on the same day as, and 7 days after, administration of a nasal influenza vaccine, and were then infected with a lethal dose of the virus 4 weeks after vaccination. Almost all mice irradiated 7 days before or on the same day as vaccination died from viral pneumonia around 7 days after the challenge infection, whereas all mice irradiated 7 days after vaccination survived with no sign of infection. In mice irradiated 7 days after vaccination, both local anti-viral IgA and systemic IgG antibodies were produced in parallel with a marked reduction in lung viral titer, although no antibody production and no reduction in lung viral titer were detected in mice irradiated 7 days before, or on the same day as, vaccination. These results clearly demonstrate that vaccination with influenza virus before irradiation can protect mice from subsequent infection. This may be applicable to patients due to receive sublethal irradiation for bone marrow transplantation.

Report this publication

Statistics

Seen <100 times